Simons Searchlight will hold the CSNK2A1, HIVEP2, MED13L and SETBP1 Family and Scientific Conference in Baltimore, MD from August 4–7, 2022, with opportunities to conduct research studies with individuals and families attending the event. Funding to conduct these studies is available. Interested researchers can apply by February 1, 2022.
Small molecules, genes and antisense oligonucleotides: Industry perspectives on treatment development for ASD
Vice President, Head of Clinical Science, Axial Therapeutics
Stuart Cobb, Ph.D.
Chief Scientific Officer, Neurogene; Research Fellow, University of Edinburgh
Yael Weiss, M.D., Ph.D.
Vice President, Business Development, Ultragenyx
Randy Carpenter, M.D.
Chief Medical Officer, Rett Syndrome Research Trust; Co-Founder, Allos Pharma
Federico Bolognani, Stuart Cobb, and Yael Weiss joined a panel to discuss new industry developments on the use of small molecules, gene therapy and antisense oligonucleotides as treatment approaches for autism spectrum disorders (ASD). The panel discussion was moderated by Randall Carpenter.
Adjunct Senior Research Fellow, Institute for Molecular Bioscience
Affiliate Professor, Queensland Brain Institute, The University of Queensland
Jake Gratten and Naomi Wray presented findings from the Australian Autism Biobank study, an initiative to establish an Australian resource of biospecimens, phenotypes and genomic data for autism research.
On March 24, 2021, SFARI held an informational session to answer questions about the 2021 Human Cognitive and Behavioral Science request for applications.
Elizabeth Berry-Kravis discussed refinements in clinical trial design and outcome measures that contributed to the success of a recent phase II trial for fragile X syndrome.
On January 26, 2021, SFARI will host a Twitter chat Q&A on the Bridge to Independence (BTI) Award program and the 2021 BTI request for applications.
SFARI hosted a virtual social focused on the Bridge to Independence (BTI) Award, in conjunction with the SfN Global Connectome: A Virtual Event on January 13, 2021.